Acute demyelination: an insight into the effect of mitoxantrone on CNS lesions.
We report the cases of 2 severely disabled patients with large inflammatory lesions suggestive of demyelination treated with mitoxantrone. Clinical condition was improved and brain lesions volume was reduced. On serial MR spectroscopy, there were variations in peaks between 0.9 and 1.4 ppm, suggestive of free lipids and amino acids. These variations may represent neurochemical markers of clinical recovery of large inflammatory lesions in multiple sclerosis.
Tourbah
A
A
Fédération de Neurologie, and INSERM U 546, Groupe Hospitalier and Faculté de Médecine Pitié-Salpêtrière (Paris VI), Paris. ayman.tourbah@psl.ap-hop-paris.fr
Stievenart
J L
JL
Edan
G
G
Abanou
A
A
Dormont
D
D
Lyon-Caen
O
O
D000208:Acute Disease; D000328:Adult; D001927:Brain Diseases / Q000188:drug therapy*; D003711:Demyelinating Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008942:Mitoxantrone / Q000627:therapeutic use*
D008942:Mitoxantrone